Founded with a mission to revolutionize gene therapy, Nanotransfer specializes in developing versatile, safe, and cost-effective nanoparticle delivery systems. Their core products are based on inorganic nanoparticles designed to enhance cellular internalization and specificity. These systems are ready-to-use, allowing clients to integrate their genetic material seamlessly. The company focuses on providing scalable solutions that can transport various types of nucleic acids, ensuring biosafety and non-immunogenic properties suitable for repeated administrations.

Nanotransfer has garnered attention from notable investors and industry experts due to its innovative approach to gene therapy. The company has achieved significant milestones in biosafety and specificity, positioning itself as a leader in the nanoparticle delivery market. Their impact is evident in the improved efficacy and reduced costs of gene therapies, making advanced treatments more accessible.